Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Vasovist contrast uptake in acute inflammatory multiple sclerosis lesions
2009-012318-33Phase 3Active
- Sponsor
- Strasbourg University Hospital
- Start
- Aug 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gadofosveset in multiple sclerosis (MS) (2 arms), sponsored by Strasbourg University Hospital. Started Aug 2009; status: active.
02
Drugs
gadofosveset
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-012318-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012318-33.